Postdischarge nutrition for high risk neonates

Ian J. Griffin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Despite improvements in neonatal care, many preterm babies suffer growth failure during their hospitalization. This appears to persist through early childhood, and possibly into adolescence. The use of enriched formulas improves the early growth of preterm infants, although most if not all of the benefit seems to be lost by 18 months. This growth benefit seems to be restricted to male infants. The improved growth does not improve developmental outcome. Although there are no direct comparisons of 22 kcal/oz post-discharge formulas and 24 kcal/oz preterm formulas, they are probably equally effective. Exactly which component (or components) of enriched formulas is responsible for this growth advantage is not known. Preliminary studies suggest that it may not be protein. Whether this growth benefit leads to decreased morbidity from cardiovascular disease in later life has not been studied. Further research is urgently needed to assess what nutritional factors can improve catch up growth in high-risk infants and whether this improved growth leads to decreased long-term morbidity.

Original languageEnglish (US)
Pages (from-to)327-344
Number of pages18
JournalClinics in Perinatology
Volume29
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Newborn Infant
Growth
Morbidity
Premature Infants
Hospitalization
Cardiovascular Diseases
Research
Proteins

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Postdischarge nutrition for high risk neonates. / Griffin, Ian J.

In: Clinics in Perinatology, Vol. 29, No. 2, 2002, p. 327-344.

Research output: Contribution to journalArticle

Griffin, Ian J. / Postdischarge nutrition for high risk neonates. In: Clinics in Perinatology. 2002 ; Vol. 29, No. 2. pp. 327-344.
@article{a515b2db08d74da3832cf1e0f47c780d,
title = "Postdischarge nutrition for high risk neonates",
abstract = "Despite improvements in neonatal care, many preterm babies suffer growth failure during their hospitalization. This appears to persist through early childhood, and possibly into adolescence. The use of enriched formulas improves the early growth of preterm infants, although most if not all of the benefit seems to be lost by 18 months. This growth benefit seems to be restricted to male infants. The improved growth does not improve developmental outcome. Although there are no direct comparisons of 22 kcal/oz post-discharge formulas and 24 kcal/oz preterm formulas, they are probably equally effective. Exactly which component (or components) of enriched formulas is responsible for this growth advantage is not known. Preliminary studies suggest that it may not be protein. Whether this growth benefit leads to decreased morbidity from cardiovascular disease in later life has not been studied. Further research is urgently needed to assess what nutritional factors can improve catch up growth in high-risk infants and whether this improved growth leads to decreased long-term morbidity.",
author = "Griffin, {Ian J.}",
year = "2002",
doi = "10.1016/S0095-5108(02)00004-0",
language = "English (US)",
volume = "29",
pages = "327--344",
journal = "Clinics in Perinatology",
issn = "0095-5108",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Postdischarge nutrition for high risk neonates

AU - Griffin, Ian J.

PY - 2002

Y1 - 2002

N2 - Despite improvements in neonatal care, many preterm babies suffer growth failure during their hospitalization. This appears to persist through early childhood, and possibly into adolescence. The use of enriched formulas improves the early growth of preterm infants, although most if not all of the benefit seems to be lost by 18 months. This growth benefit seems to be restricted to male infants. The improved growth does not improve developmental outcome. Although there are no direct comparisons of 22 kcal/oz post-discharge formulas and 24 kcal/oz preterm formulas, they are probably equally effective. Exactly which component (or components) of enriched formulas is responsible for this growth advantage is not known. Preliminary studies suggest that it may not be protein. Whether this growth benefit leads to decreased morbidity from cardiovascular disease in later life has not been studied. Further research is urgently needed to assess what nutritional factors can improve catch up growth in high-risk infants and whether this improved growth leads to decreased long-term morbidity.

AB - Despite improvements in neonatal care, many preterm babies suffer growth failure during their hospitalization. This appears to persist through early childhood, and possibly into adolescence. The use of enriched formulas improves the early growth of preterm infants, although most if not all of the benefit seems to be lost by 18 months. This growth benefit seems to be restricted to male infants. The improved growth does not improve developmental outcome. Although there are no direct comparisons of 22 kcal/oz post-discharge formulas and 24 kcal/oz preterm formulas, they are probably equally effective. Exactly which component (or components) of enriched formulas is responsible for this growth advantage is not known. Preliminary studies suggest that it may not be protein. Whether this growth benefit leads to decreased morbidity from cardiovascular disease in later life has not been studied. Further research is urgently needed to assess what nutritional factors can improve catch up growth in high-risk infants and whether this improved growth leads to decreased long-term morbidity.

UR - http://www.scopus.com/inward/record.url?scp=0035990699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035990699&partnerID=8YFLogxK

U2 - 10.1016/S0095-5108(02)00004-0

DO - 10.1016/S0095-5108(02)00004-0

M3 - Article

C2 - 12168245

AN - SCOPUS:0035990699

VL - 29

SP - 327

EP - 344

JO - Clinics in Perinatology

JF - Clinics in Perinatology

SN - 0095-5108

IS - 2

ER -